1832 Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-53,300
Closed -$2.22M 642
2020
Q1
$2.22M Buy
53,300
+15,100
+40% +$628K 0.01% 395
2019
Q4
$1.66M Buy
+38,200
New +$1.66M 0.01% 395